Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of human antibodies for treating TNF-alpha associated disorders

Formulation of human antibodies for treating TNF-alpha associated disorders

US Patent 8802100 · Granted Aug 12, 2014

Estimated economic value: $78,239,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protein formulations and methods of making same2021
Protein formulations and methods of making same2021
Formulation of human antibodies for treating TNF-alpha associated disorders2018
Formulation of human antibodies for treating TNF-alpha associated disorders2018
Formulation of human antibodies for treating TNF-alpha associated disorders2018
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017
Formulation of human antibodies for treating TNF-alpha associated disorders2017